FBIO
Fortress Biotech Inc
2.30$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 65.0% | 69.9% | 70.8% | 71.0% | 67.9% | 62.7% | 71.3% | 69.0% | 65.3% | 66.7% | 82.8% | 77.5% | |
| 49.6% | 48.3% | 52.1% | 52.3% | 46.3% | 39.7% | 51.3% | 46.5% | 47.5% | 42.8% | 71.7% | 62.1% | |
| 49.6% | 48.3% | 52.1% | 52.3% | 46.3% | 39.7% | 51.3% | 46.5% | 47.5% | 42.8% | 71.7% | 62.1% | |
| 5.4% | 9.2% | 6.1% | 7.3% | 8.5% | 7.2% | 10.3% | 10.1% | 10.0% | 16.1% | 7.1% | 11.6% | |
| 7.3% | 6.1% | 6.4% | 6.6% | 9.3% | 10.0% | 7.0% | 8.0% | 6.5% | 5.2% | 2.6% | 2.6% | |
| 14.0% | 12.1% | 11.8% | 12.8% | 14.0% | 22.1% | 17.3% | 18.6% | 15.8% | 14.9% | 7.4% | 8.1% | |
| 108.8% | 99.1% | 102.4% | 110.0% | 110.0% | 101.1% | 81.8% | 76.6% | 64.1% | 66.5% | 43.3% | 34.9% | |
| 64.7% | 50.7% | 53.3% | 51.9% | 55.3% | 49.5% | 41.4% | 36.0% | 29.8% | 26.8% | 29.0% | 19.6% | |
| 6.1% | 3.3% | 5.8% | 3.8% | 3.0% | 2.3% | 2.3% | 3.7% | 4.3% | 1.1% | 1.3% | 2.3% | |
| 29.7% | 20.8% | 25.4% | 26.1% | 26.8% | 21.9% | 15.6% | 12.6% | 10.3% | 7.7% | 4.0% | 3.7% | |
| 30.4% | 36.3% | 37.3% | 46.0% | 41.3% | 40.2% | 31.7% | 31.3% | 26.3% | 32.1% | 10.3% | 10.9% | |
| 11.1% | 13.5% | 14.0% | 12.3% | 16.6% | 15.8% | 12.5% | 27.5% | 30.8% | 26.9% | 45.5% | 51.8% | |
| -455.4% | -414.8% | -431.4% | -495.1% | -577.6% | -513.7% | -422.0% | -460.3% | -402.5% | -395.6% | -174.8% | -197.1% | |
| 5.0% | 4.7% | 10.4% | 12.6% | 15.5% | 14.0% | 14.9% | 18.7% | 18.2% | 19.3% | 10.8% | 11.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.